ArticleTherapeutic advances in chronic disease2023

Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: a meta-analysis of randomized clinical trials.

Yuqian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.